Therma Bright (TSE:THRM)
:THRM
Want to see TSE:THRM full AI Analyst Report?
THRM Stock Chart & Stats
C$0.06
>-C$0.01(-12.50%)
At close: 4:00 PM EST
C$0.06
>-C$0.01(-12.50%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.12
Previous CloseN/A
Volume10.00K
Average Volume (3M)50.06K
Market Cap
C$3.19M
Enterprise ValueC$3.22M
Total Cash (Recent Filing)C$36.19K
Total Debt (Recent Filing)C$40.00K
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding58,002,876
10 Day Avg. Volume51,225
30 Day Avg. Volume50,057
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.51
Price to Sales (P/S)48.92
P/FCF Ratio-26.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported DebtVery low reported debt (≈$40k TTM) materially reduces near-term leverage and interest burden. For a cash-burning medical-device developer this preserves financing optionality, lowers immediate default risk, and gives management room to focus on operational fixes or commercialization rather than debt servicing.
Improving Operating Cash FlowThe marked improvement in TTM operating cash flow (from larger prior outflows to ≈-165k) indicates management has meaningfully tightened cash management or working capital. If sustained, this trend extends runway, reduces near-term financing needs, and supports targeted investment in commercialization over coming quarters.
Gross Margin RecoveryRecovery to roughly 22% gross margin from prior negative margins shows progress on unit economics via pricing, cost control, or mix improvement. Durable margin improvement is a structural enabler for eventual profitability and provides buffer versus revenue swings if maintained alongside stable sales.
Bears Say
Negative Shareholders' EquityMeaningful negative equity reflects accumulated losses and weak capitalization. This impairs balance-sheet credibility, limits ability to raise non-dilutive financing or secure favorable supplier/customer terms, and elevates solvency risk absent a capital infusion or rapid return to profitability.
Persistent Cash BurnConsistent negative operating and free cash flow means the company cannot self-fund operations and will rely on external financing. Structurally this raises dilution or refinancing risk, constrains R&D and commercialization spend, and limits strategic flexibility over the medium term.
Volatile, Declining Revenue & Large LossesA declining, volatile top line combined with very large net losses indicates weak market traction and an unproven commercialization model. Without durable revenue growth and continued margin gains, the path to sustainable profitability is uncertain and may require strategic change or additional capital.
Therma Bright News
THRM FAQ
What was Therma Bright’s price range in the past 12 months?
Therma Bright lowest stock price was C$0.04 and its highest was C$0.12 in the past 12 months.
What is Therma Bright’s market cap?
Therma Bright’s market cap is C$3.19M.
When is Therma Bright’s upcoming earnings report date?
Therma Bright’s upcoming earnings report date is Jul 01, 2026 which is in 19 days.
How were Therma Bright’s earnings last quarter?
Therma Bright released its earnings results on Apr 07, 2026. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Therma Bright overvalued?
According to Wall Street analysts Therma Bright’s price is currently Overvalued.
Does Therma Bright pay dividends?
Therma Bright does not currently pay dividends.
What is Therma Bright’s EPS estimate?
Therma Bright’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therma Bright have?
Therma Bright has 58,002,876 shares outstanding.
What happened to Therma Bright’s price movement after its last earnings report?
Therma Bright reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Therma Bright?
Currently, no hedge funds are holding shares in TSE:THRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Therma Bright
Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerings include rapid COVID-19 diagnostic tests like AcuVid, which screens for both antigens and antibodies. For pain relief, they provide devices such as Benepod, a hot and cold contrast therapy system designed to manage discomfort without medication. The company also addresses circulatory issues with Venowave, a medical compression pump aimed at mitigating symptoms associated with poor circulation. Furthermore, Therma Bright caters to the cosmeceutical industry with products like InterceptCS, a cold sore prevention system utilizing safe, controlled topical heat, and TherOZap, a thermal device that alleviates the pain, itching, and inflammation from insect bites and stings by reducing the inflammatory response. Their clientele spans both individual consumers and healthcare practitioners.
Technical Analysis
―
Perimeter Medical Imaging AI
―
Profound Medical
―
Theralase Technologies
―
Aquarius Surgical Technologies
―
Options Prices
Currently, No data available
---